Award NoticePosted Aug 19, 2026

Antibacterial Nanoparticles Therapeutic (ANT) Study

Defense Health Agency · DEFENSE HEALTH AGENCY

Stage
Awarded
NAICS
541713
Value
$295K
Solicitation
HT9426-26-C-E018
Set-aside
No Set aside used
PSC
AN13
Place
Silver Spring, MD, USA
Contact
Linda Hinson (linda.t.hinson.civ@health.mil)
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation HT9426-26-C-E018 in this department, oldest first.

Early notice
None posted
Solicitation
None posted
Award
  • Aug 19, 2026 · this notice
    Award Notice
    UNIVERSITY OF NOTRE DAME DU LAC Notre Dame IN 46556 USA · $295K

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Note the winner and the end of the period of performance for the recompete.
  • Follow the agency to see the next notice for this work.

What the notice says

The Walter Reed Army Institute of Research (WRAIR), Bacterial Diseases Branch (BDB)seeks to conduct a Research and Development (R&D) study to test innovative antibacterial nanoparticles with phage-mimicking properties (PhANPs) against combat relevant multi-drug resistant (MDR) strains of Pseudomonas (P.) aeruginosa, bacterial pathogen to cause hard to treat and even deadly infections in service members after battlefield injuries. A RFI was posted pm sam.gov�s GPE on 18 March 2026 and closed on 1 April 2026, three responses were received, and the Contracting Officer�s Representative preformed a… (show all)

technical evaluation, two of the responses were deemed not capable for the requirement, and one, The University of Notre Dame, was deemed capable for the requirement. A Notice of Intent was posted on sam.gov�s GPE on 14 April 2026, with a closing date of 28 April 2026. No responses were received. Therefore, market research determined a non-commercial FAR RFO Part 13 sole source award to the University of Notre Dame to be in the best interest of the Government.

Who won similar work

9 award notices on SAM.gov in the last 24 months. Match: Same agency (Defense Health Agency), same industry group (NAICS 5417).

WinnerAwardsValueLast
CHENEGA SERVICES & FEDERAL SOLUTIONS, LLC1$72.4MMay 20, 2026
CHICKASAW SERVICE SOLUTIONS, LLC1$25.0MDec 20, 2024
HEMOGLOBIN OXYGEN THERAPEUTICS LLC1$12.5MMay 28, 2025
CHENEGA PROFESSIONAL & TECHNICAL SERVICES LLC1$11.5MSep 29, 2025
THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC.1$4.0MSep 18, 2025
MAPP BIOPHARMACEUTICAL, INC.1$2.0MJun 4, 2025
FLORIDA INSTITUE FOR HUMAN MACHINE COGNITION INC1$314KAug 26, 2025
ILLUMINA, INC. · $ILMN1$273KMay 30, 2026
POTOMAC AFFINITY PROTEINS, LLC1$110KJul 9, 2025

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.

Latest awards

Competitive landscape

For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 1 of these past winners lobbied Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff since 2024 (1 filings)
  • 0 of their lobbyists list a past Defense, Dept of (DOD) or Office of the Secretary of Defense or Joint Chiefs of Staff job
  • No corporate PAC money from them to the overseeing committees since 2024
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 1 bills named on the past winners' lobbying filings
  • 32 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.

  • 1 of the past winners are listed companies
  • 0 insider buys and 4 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.